Even though most early-stage prostate cancers have a slow course, the cancers can become more aggressive and lethal in the long term, according to a study by Swedish researchers (JAMA 2004; 291:2713-9).
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.